NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
0.6080
-0.0020 (-0.33%)
At close: Mar 28, 2025, 4:00 PM
0.6000
-0.0080 (-1.32%)
After-hours: Mar 28, 2025, 7:58 PM EST

NovaBay Pharmaceuticals Market Cap

NovaBay Pharmaceuticals has a market cap or net worth of $2.97 million as of March 28, 2025. Its market cap has increased by 230.06% in one year.

Market Cap
2.97M
Enterprise Value
3.46M
1-Year Change
230.06%
Ranking
Category
Stock Price
$0.61

Market Cap Chart

Since October 26, 2007, NovaBay Pharmaceuticals's market cap has decreased from $76.50M to $2.97M, a decrease of -96.12%. That is a compound annual growth rate of -17.00%.

History

DateMarket Cap% Change
Mar 28, 20253.00M3.45%
Dec 31, 20242.90M123.08%
Dec 29, 20231.30M-63.89%
Dec 30, 20223.60M-78.70%
Dec 31, 202116.90M-41.92%
Dec 31, 202029.10M62.57%
Dec 31, 201917.90M35.61%
Dec 31, 201813.20M-77.70%
Dec 29, 201759.20M18.64%
Dec 30, 201649.90M612.86%
Dec 31, 20157.00M-78.46%
Dec 31, 201432.50M-32.85%
Dec 31, 201348.40M43.62%
Dec 31, 201233.70M-11.32%
Dec 30, 201138.00M-1.81%
Dec 31, 201038.70M-19.21%
Dec 31, 200947.90M118.72%
Dec 31, 200821.90M-72.59%
Dec 31, 200779.90M4.44%
View and export this data all the way back to 2007. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 738.61B
UnitedHealth Group 472.03B
Johnson & Johnson 394.52B
AbbVie 363.15B
Novo Nordisk 305.46B
AstraZeneca 229.16B
Abbott Laboratories 226.88B
Merck & Co. 225.40B
Market Cap Rankings